Abstract
Risedronate reduces the risk of vertebral fractures by up to 70% within the first year of treatment. Increases in bone mineral density or decreases in bone turnover markers explain only a portion of the anti-fracture effect, suggesting that other factors, such as changes in trabecular bone architecture, also play a role. Our objective was to determine the effects of risedronate on bone architecture by analyzing iliac crest bone biopsy specimens using three-dimensional microcomputed tomography (3-D µCT). Biopsy specimens were obtained at baseline and after 1 year of treatment from women enrolled in a double-blind, placebo-controlled study of risedronate 5 mg daily for the prevention of early postmenopausal bone loss. Trabecular architecture deteriorated in the placebo group (n = 12), as indicated by a 20.3% decrease in bone volume (25.1% vs. 20.0%, P = 0.034), a 13.5% decrease in trabecular number (1.649 vs. 1.426 mm−1, P = 0.052), a 13.1% increase in trabecular separation (605 vs. 684 µm, P = 0.056), and an 86.2% increase in marrow star volume (3.251 vs. 6.053 mm3, P = 0.040) compared with baseline values. These changes in architectural parameters occurred in the presence of a concomitant decrease from baseline in lumbar spine bone mineral density (−3.3%, P = 0.002), as measured by dual energy x-ray absorptiometry. There was no statistically significant (P < 0.05) deterioration in the risedronate-treated group (n = 14) over the 1-year treatment period. Comparing the actual changes between the two groups, the placebo group experienced decreases in bone volume (placebo, −5.1%; risedronate, +3.5%; P = 0.011), trabecular thickness (placebo, −20 µm; risedronate, +23 µm; P = 0.032), and trabecular number (placebo, −0.223 mm−1; risedronate, +0.099 mm−1; P = 0.010), and increases in percent plate (placebo, +2.79%; risedronate, −3.23%; P = 0.018), trabecular separation (placebo, +79 µm; risedronate, −46 µm; P = 0.010) and marrow star volume (placebo, +2.80 mm3 ; risedronate, −2.08mm3; P = 0.036), compared with the risedronate group. These data demonstrate that trabecular architecture deteriorated significantly in this cohort of early postmenopausal women, and that this deterioration was prevented by risedronate. Although there is no direct link in this study between fracture and preservation of architecture, it is reasonable to infer that the preservation of bone architecture may play a role in risedronate’s anti-fracture efficacy.
Similar content being viewed by others
References
SR Cummings DM Black TM Vogt (1996) ArticleTitleChanges in BMD substantially underestimate the anti-fracture efficacy of alendronate and other anti-resorptive drugs. J Bone Miner Res 11 S102
S Sarkar BH Mitlak M Wong JL Stock DM Black KD Harper (2002) ArticleTitleRelationship between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 17 1–10 Occurrence Handle1:CAS:528:DC%2BD38XktFyisg%3D%3D Occurrence Handle11771654
N Watts R Bockman C Smith Z Li R Eastell S Pack R Lindsay (2000) ArticleTitleBMD changes explain only a fraction of the observed fracture risk reduction in risedronate-treated patients. Osteoporos Int (suppl 2) 546, S203
BL Riggs LJ Melton III WM O’Fallon (1996) ArticleTitleDrug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficiency. Bone 18 IssueIDsupp1 197S–201S Occurrence Handle10.1016/8756-3282(95)00502-1 Occurrence Handle1:CAS:528:DyaK28XislKjtLY%3D Occurrence Handle8777088
AM 2002 Parfitt (1996) Skeletal heterogeneity and the purpose of bone remodeling: Implications for the understanding of osteoporosis. R Marcus D Feldman J Kelsey (Eds) Osteoporosis. Academic Press San Diego, CA, USA 315–329
CH Chestnut III CJ Rosen (2001) ArticleTitleReconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res 16 2163–2172 Occurrence Handle1:CAS:528:DC%2BD38XhtlSisg%3D%3D Occurrence Handle11760829
CH Turner (2002) ArticleTitleBiomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int 13 97–104 Occurrence Handle1:STN:280:DC%2BD387ntlaguw%3D%3D Occurrence Handle11905527
ST Harris NB Watts HK Genant et al. (1999) ArticleTitleEffects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 282 1344–1352 Occurrence Handle1:CAS:528:DyaK1MXmvFansr0%3D Occurrence Handle10527181
J-Y Reginster HW Minne OH Sorensen et al. (2000) ArticleTitleRandomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11 83–91 Occurrence Handle1:CAS:528:DC%2BD3cXhvFGgsr0%3D Occurrence Handle10663363
S Wallach S Cohen DM Reid et al. (2000) ArticleTitleEffects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 67 277–285 Occurrence Handle10.1007/s002230001146 Occurrence Handle1:CAS:528:DC%2BD3cXntlOlu74%3D Occurrence Handle11000340
Z Li MP Meredith M Hoseyni (2001) ArticleTitleA method to assess the proportion of treatment effect explained by a surrogate endpoint. Stat in Med 20 3175–3188 Occurrence Handle10.1002/sim.984.abs Occurrence Handle1:STN:280:DC%2BD3MnpvVyktg%3D%3D
R Eastell I Barton RA Hannon A Chines P Garnero PD Delmas (2003) ArticleTitleRelationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 18 1051–1056 Occurrence Handle1:CAS:528:DC%2BD3sXkslOhsb0%3D Occurrence Handle12817758
AM Parfitt (1992) ArticleTitleImplications of architecture for the pathogenesis and prevention of vertebral fracture. Bone 13 S41–S47
DW Dempster F Cosman ES Kurland et al. (2001) ArticleTitleEffects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16 1846–1853 Occurrence Handle1:CAS:528:DC%2BD3MXnsVKqtLw%3D Occurrence Handle11585349
R Nuzzo MH Lafage-Proust E Martin-Badosa G Boivin T Thomas C Alexandre F Peyrin (2002) ArticleTitleSynchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. J Bone Miner Res 17 1372–1382 Occurrence Handle1:STN:280:DC%2BD38vgvVajug%3D%3D Occurrence Handle12162491
L Mortensen P Charles PJ Bekker J Digennaro CC Johnston (1998) ArticleTitleRisedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab 83 396–402 Occurrence Handle1:CAS:528:DyaK1cXhtVSmsro%3D Occurrence Handle9467547
EF Eriksen (1986) ArticleTitleNormal and pathological remodeling of human trabecular bone: three-dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev 7 379–408 Occurrence Handle1:STN:280:BiiD2MzntVU%3D Occurrence Handle3536460
P Ruegsegger B Koller R Muller (1996) ArticleTitleA microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int 58 24–29 Occurrence Handle10.1007/s002239900006 Occurrence Handle8825235
Chmielewski PA (1999) Validation of a micro-CT system for the 3-D measurement of bone. Presented at the VIIIth Congress of the International Society of Bone Morphometry. Scottsdale, AZ, Oct 6–10, 1999
TE Dufresne (1998) ArticleTitleSegmentation techniques for analysis of bone by three-dimensional computed tomographic imaging. Technol Health Care 6 351–359 Occurrence Handle1:STN:280:DyaK1M7pvFSgtQ%3D%3D Occurrence Handle10100938
T Hildebrand P Ruegsegger (1997) ArticleTitleA new method for the model-independent assessment of thickness in three-dimensional images. J Microsc 185 67–75 Occurrence Handle10.1046/j.1365-2818.1997.1340694.x
T Hildebrand A Laib R Muller J Dequeker P Ruegsegger (1999) ArticleTitleDirect three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14 1167–1174 Occurrence Handle1:STN:280:DyaK1MzjtlKisA%3D%3D Occurrence Handle10404017
A Odgaard HJ Gundersen (1993) ArticleTitleQuantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. Bone 14 173–182 Occurrence Handle1:STN:280:ByyA38nks1E%3D Occurrence Handle8334036
A Vesterby (1993) ArticleTitleMarrow space star volume can reveal change of trabecular connectivity. Bone 14 193–197 Occurrence Handle1:STN:280:ByyA2s7os1U%3D Occurrence Handle8363856
B Borah TE Dufresne MD Cockman GJ Gross EW Sod WR Myers KH Combs RE Higgins SA Pierce ML Stevens (2000) ArticleTitleEvaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling. J Bone Miner Res 15 1786–1797 Occurrence Handle1:STN:280:DC%2BD3M%2FotlOiug%3D%3D Occurrence Handle10976998
B Borah TE Dufresne PA Chmielewski GJ Gross MC Prenger RJ Phipps (2002) ArticleTitleRisedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by 3-D microcomputed tomography. J Bone Miner Res 17 1139–1147 Occurrence Handle1:CAS:528:DC%2BD38XlsF2nurs%3D Occurrence Handle12096826
DW Dempster (1995) Bone remodeling. Osteoporosis. BL Riggs LJ Melton III (Eds) Etiology diagnosis and management, 2nd ed. Lippincott_Raven Philadelphia 67–91
J Kanis (1996) Textbook of osteoporosis. Blackwell Science Ltd Cambridge, Mass
AM Parfitt CH Mathews AR Villanueva M Kleerekoper B Frame DS Rao (1983) ArticleTitleRelationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72 1396–1409 Occurrence Handle1:STN:280:BiuD3szhs1w%3D Occurrence Handle6630513
RP Heaney AJ Yates AC Santora II (1997) ArticleTitleBisphosphonate effects and the bone remodeling transient. J Bone Miner Res 12 1143–1151 Occurrence Handle1:STN:280:ByiH3czjslA%3D Occurrence Handle9258743
PD Delmas (2000) ArticleTitleHow does anti-resorptive therapy decrease the risk of fracture in women with osteoporosis. Bone 27 1–3 Occurrence Handle10.1016/S8756-3282(00)00301-X Occurrence Handle1:STN:280:DC%2BD3cvisVChtA%3D%3D Occurrence Handle10865202
GY Boivin PM Chavassieux AC Santora J Yates PJ Meunier (2000) ArticleTitleAlendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27 687–694
P Roschger S Rinnerthaler J Yates GA Rodan P Fratzl K Klaushofer (2001) ArticleTitleAlendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29 185–191 Occurrence Handle10.1016/S8756-3282(01)00485-9 Occurrence Handle1:CAS:528:DC%2BD3MXlvFWkurk%3D Occurrence Handle11502482
Day J, Ding M, Bednarz P, et al. (2002) Transactions of the 48th Annual Orthopaedic Research Society Meeting, 27:85
MJ Silva LJ Gibson (1997) ArticleTitleModeling the mechanical behavior of vertebral trabecular bone: effects of age-related changes in microarchitecture. Bone 21 IssueIDSupp 2 191–199 Occurrence Handle10.1016/S8756-3282(97)00100-2 Occurrence Handle1:STN:280:ByiH3MzgsFY%3D Occurrence Handle9267695
D Chappard E Legrand MF Basle P Fromont JL Racineux A Rebel M Audran (1996) ArticleTitleAltered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res 11 676–685 Occurrence Handle1:STN:280:ByiD3M3mvVQ%3D Occurrence Handle9157783
D Ulrich B van Rietbergen A Laib P Ruegsegger (1999) ArticleTitleThe ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25 55–60 Occurrence Handle10.1016/S8756-3282(99)00098-8 Occurrence Handle1:STN:280:DyaK1MzkvFyrtw%3D%3D Occurrence Handle10423022
B Borah TE Dufresne PA Chmielewski MC Prenger EF Eriksen (2001) ArticleTitleRisedronate (Ris) preserves bone architecture in osteoporotic postmenopausal women as measured by 3-D microcomputed tomography (abstract). J Bone Miner Res 16 IssueIDsuppl 1 S218
E Eriksen F Melsen E Sod I Barton A Chines (2002) ArticleTitleEffects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone 31 620–625 Occurrence Handle10.1016/S8756-3282(02)00869-4 Occurrence Handle1:CAS:528:DC%2BD38XptlGisrk%3D Occurrence Handle12477578
Y Jiang J Zhao EF Eriksen O Wang HK Genant BH Mitlak (2002) ArticleTitleImproved 3-dimensional microarchitecture of cancellous and cortical bone in a multicenter, double-blind, randomized and placebo-controlled study of Teriparatide [rhPTH(1-34) (abstract). J Bone Miner Res 17 IssueIDsuppl 1 S135
P Meunier P Courpron C Edouard J Bernard J Bringuner G Vignon (1973) ArticleTitlePhysiological senile involution and pathological rarefaction of bone. Clin Endocrinol Metab 2 239–256 Occurrence Handle1:STN:280:CSqD2MjgtFM%3D Occurrence Handle4548004
A Oleksik SM Ott S Vedi N Bravenboer J Compston P Lips (2000) ArticleTitleBone structure in patients with low bone mineral density with and without vertebral fractures. J Bone Miner Res 15 1368–1375 Occurrence Handle1:STN:280:DC%2BD3M%2FhtF2jsA%3D%3D Occurrence Handle10893686
DB Kimmel RR Recker JC Gallagher AS Vaswani JF Aloia (1990) ArticleTitleA comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects. Bone Miner 11 217–235 Occurrence Handle1:STN:280:By6D1Mfjs10%3D Occurrence Handle2268749
M Kleerekoper AR Villanueva J Stanciu DS Rao AM Parfitt (1985) ArticleTitleThe role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int 37 594–597 Occurrence Handle1:STN:280:BimC3s3ovFc%3D Occurrence Handle3937580
L Mosekilde A Viidik L Mosekilde (1985) ArticleTitleCorrelation between the compressive strength of iliac crest and vertebral trabecular bone in normal individuals. Bone 6 291–295 Occurrence Handle1:STN:280:BimC2MbjvFQ%3D Occurrence Handle4096861
PD Delmas (2002) ArticleTitleDifferent effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis. Bone 30 14–17 Occurrence Handle10.1016/S8756-3282(01)00667-6 Occurrence Handle1:CAS:528:DC%2BD38XktFerug%3D%3D Occurrence Handle11792559
Acknowledgements
We thank Lisa Bosch for editorial suggestions and technical insight in writing this manuscript, Arkadi Chines and Roger Phipps for providing important technical insight and feedback and Marla Gross for additional statistical analysis of the data. We also thank Dr. Erik Eriksen for performing the conventional histomorphometric assessments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dufresne, T., Chmielewski, P., Manhart, M. et al. Risedronate Preserves Bone Architecture in Early Postmenopausal Women In 1 Year as Measured by Three-Dimensional Microcomputed Tomography . Calcif Tissue Int 73, 423–432 (2003). https://doi.org/10.1007/s00223-002-2104-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-002-2104-4